New Delhi: Health ministry officials said on Thursday the decision to administer a combination of anti-HIV drugs lopinavir and ritonavir on a coronavirus-infected elderly Italian couple at a Jaipur hospital was "initially taken locally".
The hospital has been asked to inform the health ministry and the Indian Council of Medical Research (ICMR) before administering the drug combination on COVID-19 patients in future, officials said.
It was the first time that a combination of the two drugs was used to treat Covid-19 patients amid mounting coronavirus cases in India. The Italian couple is currently undergoing treatment at SMS Hospital in Jaipur.
"The decision to administer lopinavir and ritonavir combination initially was taken locally as they thought it was a severe disease and started the medicine. But we should not draw more conclusions from the same because single patient experiments do not reveal the truth more often. We need to have a structured study," Raman R Gangakhedkar, the head of the Epidemiology and Communicable Diseases-I at ICMR, said.
"Until we have a large data that come from such experiments we won't be able to infer more. But since the drug was administered we have pressed into a study mode where the samples are being regularly collected in order to see if the drug was efficacious," he said.
ALSO READ:Stay put, travel only under compelling reasons: MEA on Coronavirus
Dr S Meena, the medical superintendent of SMS Hospital, said the decision to administer the combination of lopinavir and ritonavir was taken after the Italian man and his wife had developed severe respiratory problems.